Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Biomed Pharmacother. 2016 Dec 24;86:590–594. doi: 10.1016/j.biopha.2016.11.104

Fig. 1.

Fig. 1

The proposed mechanisms supporting resistant hypertension development in the hypertensive elderly subjects are shown. Chronic kidney disease and hyperuricemia (i.e. serum uric acid ≥6.8 mg/dl) independently increase the risk of resistant hypertension by volume expansion (left side) and vascular remodelling respectively (right side).